Diabetes, hyperglycemia, and inflammation in older individuals - The health, aging and body composition study

被引:153
作者
De Rekeneire, Nathalie
Kritchevsky, Stephen B.
Peila, Rita
Kuller, Lewis H.
Ding, Jingzhong
Strotmeyer, Elsa S.
Colbert, Lisa H.
Schwartz, Ann V.
Visser, Marjolein
Vellas, Bruno
Shorr, Ronald I.
Harris, Tamara B.
机构
[1] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA
[2] Sticht Ctr Aging, Winston Salem, NC USA
[3] Univ Wisconsin, Dept Kinesiol, Madison, WI USA
[4] Vrije Univ Amsterdam, Ctr Med, Dept Nutr & Hlth, Amsterdam, Netherlands
[5] Univ Tennessee, Dept Prevent Med, Memphis, TN USA
[6] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA USA
[7] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
D O I
10.2337/dc05-2327
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The objective of this study was to assess the association of inflammation with hyperglycemia (impaired fasting glucose [IFG]/impaired glucose tolerance [IGT] and diabetes in older individuals. RESEARCH DESIGN AND METHODS - Baseline data from the Health, Aging and Body Composition study included 3,075 well-functioning black and white participants, aged 70-79 years. RESULTS - Of the participants, 24% had diabetes and 29% had IFG/IGT at baseline. C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) levels (P < 0.001) were significantly higher among diabetic participants and those with IFG/IGT. Odds of elevated IL-6 and TNF-alpha (> 75th percentile) were, respectively, 1-95 (95% CI 1.56-2.44) and 1.88 (1.51-2.35) for diabetic participants and 1.51 (1.21-1.87) and 1.14 (0.92-1.42) for those with IFG/IGT after adjustment for age, sex, race, smoking, alcohol intake, education, and study site. Odds ratios for elevated CRP were 2.90 (2.13-3.95) and 1.45 (1.03-2.04) women and men and 1.33 (1.07-1.69) for those with IFG/IGT regardless of sex. After adjustment for obesity, fat distribution, and inflammation-related conditions, IL-6 remained significantly related to both diabetes and IFG/IGT. CRP in women and TNF-alpha. in both sexes were significantly related to diabetes, respectively, whereas risk estimates for IFG/IGT were decreased by adjustment for adiposity. Among diabetic participants, higher levels of HbA(1c) were associated with higher levels of all three markers of inflammation, but only CRP remained significant after full adjustment. CONCLUSIONS - Our findings show that dysglycemia is associated with inflammation, and this relationship, although consistent in diabetic individuals, also extends to those with IFG/IGT.
引用
收藏
页码:1902 / 1908
页数:7
相关论文
共 44 条
[11]   Body mass index, diabetes, and C-reactive protein among US adults [J].
Ford, ES .
DIABETES CARE, 1999, 22 (12) :1971-1977
[12]   Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians [J].
Forouhi, NG ;
Sattar, N ;
McKeigue, PM .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (09) :1327-1331
[13]   C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study [J].
Freeman, DJ ;
Norrie, J ;
Caslake, MJ ;
Gaw, A ;
Ford, I ;
Lowe, GDO ;
O'Reilly, DS ;
Packard, CJ ;
Sattar, N .
DIABETES, 2002, 51 (05) :1596-1600
[14]   Association between C-reactive protein and features of the metabolic syndrome -: A population-based study [J].
Fröhlich, M ;
Imhof, A ;
Berg, G ;
Hutchinson, WL ;
Pepys, MB ;
Boeing, H ;
Muche, R ;
Brenner, H ;
Koenig, W .
DIABETES CARE, 2000, 23 (12) :1835-1839
[15]  
Genuth S, 2003, DIABETES CARE, V26, P3160
[16]   Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly [J].
Harris, TB ;
Ferrucci, L ;
Tracy, RP ;
Corti, MC ;
Wacholder, S ;
Ettinger, WH ;
Heimovitz, H ;
Cohen, HJ ;
Wallace, R .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) :506-512
[17]   Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension [J].
Hashimoto, K ;
Kasayama, S ;
Yamamoto, H ;
Kurebayashi, S ;
Kawase, I ;
Koga, M .
DIABETIC MEDICINE, 2004, 21 (06) :581-585
[18]  
Hill JO, 1999, AM J CLIN NUTR, V69, P381
[19]   INCREASED ADIPOSE-TISSUE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN OBESITY AND INSULIN-RESISTANCE [J].
HOTAMISLIGIL, GS ;
ARNER, P ;
CARO, JF ;
ATKINSON, RL ;
SPIEGELMAN, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2409-2415
[20]   Troglitazone reduces plasma levels of tumour necrosis factor-α in obese patients with type 2 diabetes [J].
Katsuki, A ;
Sumida, Y ;
Murata, K ;
Furuta, M ;
Araki-Sasaki, R ;
Tsuchihashi, K ;
Hori, Y ;
Yano, Y ;
Gabazza, EC ;
Adachi, Y .
DIABETES OBESITY & METABOLISM, 2000, 2 (03) :189-191